Current Liabilities
Other Commercial Liabilities
Roivant Sciences Other Commercial Liabilities increased by 74.4% to $205.82M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 80.1%, from $114.29M to $205.82M. Over 5 years (FY 2020 to FY 2025), Other Commercial Liabilities shows an upward trend with a 21.8% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Liabilities
First reportedQ4 2014
Last reportedQ3 2024
Metric ID:
commercial_liabilities_otherHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $73.79M | $104.11M | $112.68M | $127.53M | $109.35M | $128.82M | $132.36M | $167.13M | $119.33M | $152.92M | $122.15M | $119.42M | $138.29M | $111.47M | $104.32M | $114.29M | $88.73M | $108.32M | $117.99M | $205.82M |
| QoQ Change | — | +41.1% | +8.2% | +13.2% | -14.3% | +17.8% | +2.8% | +26.3% | -28.6% | +28.2% | -20.1% | -2.2% | +15.8% | -19.4% | -6.4% | +9.6% | -22.4% | +22.1% | +8.9% | +74.4% |
| YoY Change | — | — | — | — | +48.2% | +23.7% | +17.5% | +31.0% | +9.1% | +18.7% | -7.7% | -28.5% | +15.9% | -27.1% | -14.6% | -4.3% | -35.8% | -2.8% | +13.1% | +80.1% |
Range$73.79M – $205.82M
CAGR+24.1%
Avg YoY Growth+8.5%
Median YoY Growth+11.1%
Current Streak3 quarters growth
Other Commercial Liabilities at Other Companies
Frequently Asked Questions
- What is Roivant Sciences's other commercial liabilities?
- Roivant Sciences (ROIV) reported other commercial liabilities of $205.82M in Q1 2026.
- How has Roivant Sciences's other commercial liabilities changed year-over-year?
- Roivant Sciences's other commercial liabilities increased by 80.1% year-over-year, from $114.29M to $205.82M.
- What is the long-term trend for Roivant Sciences's other commercial liabilities?
- Over 5 years (2020 to 2025), Roivant Sciences's other commercial liabilities has grown at a 21.8% compound annual growth rate (CAGR), from $76.94M to $205.82M.